Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 1.42% | $447.66M | €318.58B | 30.04% | 76 Outperform | |
| Samsung Electronics | 1.17% | $368.56M | $417.40B | 62.92% | ― | |
| AstraZeneca | 0.97% | $306.72M | £214.25B | 31.94% | 76 Outperform | |
| Roche Holding AG | 0.96% | $303.13M | CHF252.45B | 36.57% | 73 Outperform | |
| Nestlé SA | 0.92% | $288.86M | CHF204.13B | 16.22% | 71 Outperform | |
| Novartis AG | 0.86% | $272.18M | CHF195.80B | 9.82% | 80 Outperform | |
| SAP SE | 0.86% | $269.30M | €239.26B | -9.26% | 66 Neutral | |
| Toyota Motor | 0.84% | $265.37M | ¥40.36T | 16.23% | 81 Outperform | |
| HSBC Holdings | 0.84% | $265.34M | £178.86B | 43.76% | 79 Outperform | |
| Shell (UK) | 0.77% | $242.56M | £159.68B | 6.99% | 77 Outperform |